GOLYTELY: payments to doctors
Payments that named GOLYTELY as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $9.5M
- Providers
- 3
- Transactions
- 172
- Average per transaction
- $55,511
The per-transaction average — $55,511 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3 providers the average total is $3,182,643, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Braintree Laboratories, Inc. | $9,419,634 | 98.7% |
| Affordable Pharmaceuticals, LLC | $128,295 | 1.3% |